BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34830452)

  • 1. Cervical Carcinoma: Oncobiology and Biomarkers.
    Volkova LV; Pashov AI; Omelchuk NN
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basaloid Squamous Cell Carcinoma of the Uterine Cervix: Report of a Case With Molecular Analysis.
    Munkhdelger J; Shimooka T; Koyama Y; Ikeda S; Mikami Y; Fukuoka J; Hori T; Bychkov A
    Int J Surg Pathol; 2021 Oct; 29(7):770-774. PubMed ID: 33792431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma.
    Zhu J; Zhao R; Xu W; Ma J; Ning X; Ma R; Meng F
    Biosci Trends; 2020 Sep; 14(4):279-284. PubMed ID: 32536673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA sequencing of cervical exfoliated cells reveals potential biomarkers and cellular pathogenesis in cervical carcinogenesis.
    Sheng B; Pan S; Ye M; Liu H; Zhang J; Zhao B; Ji H; Zhu X
    Cell Death Dis; 2024 Feb; 15(2):130. PubMed ID: 38346944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tissue collagenase MMP-14 and endogenous regulators of its activity in the corpus uteri in squamous cell carcinoma of the cervix].
    Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Andreeva YY; Solovyeva NI
    Arkh Patol; 2017; 79(6):36-42. PubMed ID: 29265076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of biomarkers in cervical squamous cell carcinomas via gene expression profiling.
    Chen B; Li C; Zhang L; Lv J; Tong Y
    Mol Med Rep; 2015 Nov; 12(5):6985-9. PubMed ID: 26398134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L1 cell adhesion molecule (L1CAM) in stage IB cervical cancer: distinct expression in squamous cell carcinomas and adenocarcinomas.
    Mancusi de Carvalho JP; Salim RC; Carvalho FM; Nogueira Dias Genta ML; Baracat EC; Carvalho JP
    J Clin Pathol; 2020 Nov; 73(11):748-753. PubMed ID: 32366597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic accuracy of cervical cone biopsy.
    Albrechtsen R; Koch F
    Dan Med Bull; 1972 Jun; 19(4):119-21. PubMed ID: 4557446
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of microRNA expression signature for the diagnosis and prognosis of cervical squamous cell carcinoma.
    Bozgeyik E; Tepe NB; Bozdag Z
    Pathol Res Pract; 2020 Nov; 216(11):153159. PubMed ID: 32841775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krüppel-like factor 5 as potential molecular marker in cervical cancer and the KLF family profile expression.
    Marrero-Rodríguez D; Taniguchi-Ponciano K; Jimenez-Vega F; Romero-Morelos P; Mendoza-Rodríguez M; Mantilla A; Rodriguez-Esquivel M; Hernandez D; Hernandez A; Gomez-Gutierrez G; Muñoz-Hernandez N; la Cruz HA; Vargas-Requena C; Díaz-Hernández C; Serna-Reyna L; Meraz-Rios M; Bandala C; Ortiz-Leon J; Salcedo M
    Tumour Biol; 2014 Nov; 35(11):11399-407. PubMed ID: 25119587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
    Bhat S; Kabekkodu SP; Varghese VK; Chakrabarty S; Mallya SP; Rotti H; Pandey D; Kushtagi P; Satyamoorthy K
    Tumour Biol; 2017 Mar; 39(3):1010428317694573. PubMed ID: 28351298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of chromosomal aneuploidy in cervical atypia, carcinoma in situ and invasive carcinoma of the uterine cervix.
    Jones HW; Woodruff JD; Davis HJ; Katayama KP; Salimi R; Park IJ; Tseng PY; Preston E
    Johns Hopkins Med J; 1970 Sep; 127(3):125-35. PubMed ID: 5472456
    [No Abstract]   [Full Text] [Related]  

  • 13. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix.
    Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L
    Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant microRNA expression in human cervical carcinomas.
    Rao Q; Shen Q; Zhou H; Peng Y; Li J; Lin Z
    Med Oncol; 2012 Jun; 29(2):1242-8. PubMed ID: 21264530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
    Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
    PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma.
    Lee JS; Choi YD; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Kim HS; Min KW
    J Surg Oncol; 2006 Mar; 93(3):233-40. PubMed ID: 16482604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression identified in Uigur women cervical squamous cell carcinoma by suppression subtractive hybridization.
    Pan Z; Chen S; Pan X; Wang Z; Han H; Zheng W; Wang X; Li F; Qu S; Shao R
    Neoplasma; 2010; 57(2):123-8. PubMed ID: 20099975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations and clinical relevance in cervical carcinoma and precursors (Review).
    Sheng J; Xiang Y; Shang L; He Q
    Oncol Rep; 2020 Dec; 44(6):2397-2405. PubMed ID: 33125112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome.
    Holm R; Ali T; Svendsrud DH; Nesland JM; Kristensen GB; Lyng H
    Oncol Rep; 2009 Jul; 22(1):11-5. PubMed ID: 19513498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD 44 exon v6 as a predictor of lymphatic metastases in cervical carcinoma--an immunocytochemical study of 94 cases.
    Biesold C; Köhler U; Horn LC; Bilek K; Kade R; Emmert C
    Arch Gynecol Obstet; 1995; 256(3):147-53. PubMed ID: 7574907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.